Genzyme selling diagnostics business for $265 million
Genzyme Corp. sells off its diagnostics business to Sekisui Chemical Co. Ltd. for $265 million in cash. Genzyme Corp. (NSDQ:GENZ) is planning to sell off its diagnostics business to Tokyo-based Sekisui Chemical Co. Ltd. (TYO:4204) for $265 million in cash. The Cambridge, Mass.-based biotech giant said Sekisui will buy “substantially all of the assets” of […]